Brief: Calithera Biosciences Announces Board Approval Of Complete Liquidation And Dissolution
Calithera Biosciences Inc CALA.O :
* CALITHERA BIOSCIENCES ANNOUNCES BOARD APPROVAL OF COMPLETE
LIQUIDATION AND DISSOLUTION
* CALITHERA BIOSCIENCES INC- CALITHERA IS DISCONTINUING ALL
CLINICAL DEVELOPMENT PROGRAMS AND REDUCING ITS WORKFORCE,
INCLUDING TERMINATION OF MOST EMPLOYEES BY END OF Q1
* CALITHERA BIOSCIENCES- BOARD DETERMINED IT IS IN BEST
INTERESTS
OF SHAREHOLDERS TO LIQUIDATE CO'S ASSETS, FOLLOWING ORDERLY WIND
DOWN OF CO'S OPERATIONS
Source text for Eikon: ID:nGNX3DSL2k
Further company coverage: CALA.O
Recent news on Calithera Biosciences
See all newsBrief: Calithera Biosciences Announces Update On Complete Liquidation And Dissolution
Brief: Calithera Biosciences Announces Update On Complete Liquidation And Dissolution
Brief: Calithera Biosciences Receives Notice Of Delisting Or Failure From Nasdaq
Calithera slumps as board approves company liquidation and dissolution
Brief: Calithera Biosciences Announces Board Approval Of Complete Liquidation And Dissolution